Pfizer and BioNTech today announced updated top results from analysis of 927 confirmed symptomatic cases of COVID-19 observed in their pivotal Phase 3 study through March 13, 2021, showing the…
Pfizer
-
-
The question of how long vaccine protection lasts can only be answered once enough time has passed, and while six months of protection is a modest target, it’s longer than…
-
Pfizer announced Wednesday that its COVID-19 vaccine is safe and strongly protective in kids as young as 12, a step toward possibly beginning shots in this age group before they…
-
The Pfizer / BioNTech COVID-19 vaccine is highly effective in 12- to 15-year-olds, the companies announced today in a press release. None of the children who received the vaccine in…
-
A nurse Cindy Mendez wearing a protective mask holds a syringe with a dose of the Pfizer-BioNTech COVID-19 vaccine during the coronavirus disease (COVID-19) pandemic, at NYC Health + Hospitals…
-
Pfizer announced Wednesday that its COVID-19 vaccine is safe and strongly protective in kids as young as 12, a step toward possibly beginning shots in this age group before they…
-
BioNTech-Pfizer said today their vaccine showed 100 percent efficacy against the coronavirus in 12 to 15-year-olds, as they eye approval for adolescents to get the jabs before the next school…
- News
One dose of Pfizer or Moderna vaccines was 80% effective in preventing Covid in CDC study of health workers
A single dose of Pfizer or Moderna’s Covid-19 vaccines was 80% effective in preventing coronavirus infections, according to a new Centers for Disease Control and Prevention study of vaccinated health-care…
-
An earlier real world study had showed effectiveness at preventing symptomatic disease at 94% and asymptomatic illness at 92%. Pfizer Inc and BioNTech SE said that real-world data from Israel…
-
Pfizer Inc and BioNTech SE said on Wednesday that real-world data from Israel suggests that their COVID-19 vaccine is 94% effective in preventing asymptomatic infections, meaning the vaccine could significantly…
-
For people who have had Covid-19, a single dose of the Pfizer vaccine is enough to provide robust protection from the coronavirus, according to two new studies from Britain that…
-
Hunt said the vaccines landed in Sydney just after midday on Monday and would go through security and quality-assurance processes, including batch testing, before the rollout began on February 22,…
-
The executive in charge of Pfizer’s global supply chain said Sunday he’s hopeful the pharmaceutical giant will iver two billion doses of its COVID-19 vaccine by the end of the…
-
Text size The State of Wisconsin Investment Board added to positions in GE, Zoom Video, and Pfizer stock, and cut a position in Intel stock in the fourth quarter. Loic…
- Science
Moderna and Pfizer vaccines neutralise variants encoding mutations E484K or N501Y but with less potency
Individuals immunized with either Moderna or Pfizer-BioNTech vaccines produce closely related and nearly identical antibodies In a small cohort involving just 20 trial participants, researchers have found that both Moderna…
- Science
Pfizer vaccine can neutralise coronavirus variants first reported in U.K., South Africa: Study
In the current study, the scientists engineered combinations of mutations found in these circulating variants and tested a panel of human sera from 20 participants The COVID-19 vaccine co-developed by…
-
Pfizer Inc said on Friday (February 5) that it had withdrawn an application for emergency-use authorisation of its COVID-19 vaccine in India, after failing to meet the drug regulator’s demand…
-
Pharma major Pfizer on Friday said it has decided to withdraw its application for Emergency Use Authorisation (EUA) of its COVID-19 vaccine in India. Pfizer was the first pharmaceutical firm…
- Business
Pfizer plans to deliver 200 million doses of Covid vaccine to U.S. by May, sooner than expected
A vaccination tray of Pfizer BioNtech vaccines. Matthias Bein | picture alliance | Getty Images Pfizer plans to iver 200 million doses of its coronavirus vaccine to the U.S. by…
-
Empty vials of the Pfizer COVID-19 vaccine are seen at a first come first serve drive-thru vaccination site operated by the Lake County Health Department on January 28, 2021 in…
-
s of Pfizer Inc. PFE, -0.28% slipped 0.6% in premarket trading Tuesday, after the drug maker reported fourth-quarter profit that missed expectations, but revenue that beat forecasts and provided an…
- News
Pfizer, Moderna, Astrazeneca, Bharat Biotech, other COVID-19 vaccines in use or getting close- Technology News, Firstpost
The Associated PressFeb 01, 2021 15:25:05 IST While a few have already hit the market, there are still dozens of coronavirus vaccines in development around the globe. Some use tried-and-true…
-
Text size Fourth-quarter earning season continues this week, with 99 S&P 500 companies reporting. NXP Semiconductors and Otis Worldwide kick things off on Monday, followed by several big names on Tuesday: Alphabet,…
-
This week the market has loed increasingly like a game, given the next big thing that’s swept over Wall Street. But when it comes to Pfizer (NYSE:PFE), owning s is…
-
Monday (February 1) Tuesday (February 2) Wednesday (February 3) Thursday (February 4) Friday (February 5) Earnings Calendar For The Week Of February 1 Monday (February 1) IN THE SPOTLIGHT: VERTEX…
- Business
The Week Ahead In Biotech: Merck, Pfizer In Earnings Mix, Plus Adamas, Mallinckrodt FDA Decisions, IPOs And More
InvestorPlace 7 Tech Stocks That Could Be the Future FAANG A few months ago, I began prodding around the idea of, “What are the future FAANG stocks?” We’ve seen Apple…